Tag Archives: drug policy

‘Litmus test’ must not be a four-letter word

I have long wondered why the term “litmus test” has become a sort of plague to politicians running for offices that hold the power of appointment.

The U.S. Supreme Court, for instance, is going to become a key issue in the 2020 presidential campaign. Namely, the issue will revolve a potential appointment of the next justice on the nine-member court.

The expected Republican presidential nominee, Donald Trump, will insist he would appoint justices with a record of favoring pro-life litigants who would come before his or her court. Indeed, he’s already got two judicial appointments on the SCOTUS and they certainly seem to fit the bill prescribed by what Trump has said.

The large field of Democratic Party candidates will argue to a person that they want judicial candidates who take a more expansive view of a woman’s right to terminate a pregnancy.

But no one says they will apply a “litmus test” to determine who they intend to nominate the highest court in the nation.

They dance all over and around the issue. Litmus tests exist on all sorts of issues. They involve capital punishment, sentencing guidelines, drug policy, firearm ownership and, yes, abortion.

We know the types of individuals that presidents would nominate. They telegraph that punch before they deliver it. However, we refuse to hold them accountable on whether they are applying litmus tests on the individuals they are considering for these appointments.

U.S. senators who have the right to confirm or deny these appointments often make their decisions on single issues. Yet they won’t ever acknowledge they have applied a litmus test to the nominee, indicating whether they pass or fail the exam.

This is a circuitous way of saying, I suppose, that we apply litmus tests at every turn.

Why not, then, just call them what we know them to be?

Drug czar nominee bails out of Trump’s team

Don’t you just love it when the media reveal potential corruption in government at the highest levels?

Consider what happened to U.S. Rep. Tom Marino.

He was supposed to become Donald J. Trump’s “drug czar,” the director of drug policy. Then came “60 Minutes” and The Washington Post to reveal to the nation that Marino sought to enact legislation that crippled the nation’s fight against opioid abuse.

If you’ll allow me to once again borrow a phrase from former GOP presidential candidate Rick Perry: Oops!

The former Texas governor and current energy secretary made that statement famous when he couldn’t name the third federal agency he would dissolve.

Look for a new drug czar

Now comes this latest bit of embarrassment for the president, who nominated Rep. Marino to lead an effort after he sought to torpedo the nation’s effort to combat drug abuse.

My question for the president’s team is this: Is anyone in the White House personnel office vetting these candidates for important public policy positions?

It appears that no one in Trump’s White House team is capable of doing just a bit of homework on the people they seek to install in these posts. Marino’s public record as a Pennsylvania congressman is known to anyone who takes the time to look at it.

As Politico reports: Marino had faced growing resistance to his nomination since this past weekend, when a report by “60 Minutes” and The Washington Post detailed how he championed legislation that makes it essentially impossible for the Drug Enforcement Administration to freeze suspicious narcotics shipments from drug distribution companies, according to officials at the DEA and Justice Department.

The 2016 law, signed by former President Barack Obama and unanimously approved by Congress, overturned longstanding DEA policy and established a much higher bar before the agency could take some actions to halt suspicious shipments.

The task now for the president is clear: Find a drug czar nominee who operates far from the political circus in Washington; find someone with a demonstrated commitment to battling the nation’s drug crisis.